NCT02129101
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +32 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Myelodysplastic/Myeloproliferative Neoplasm
Explore clinical trials studying Myelodysplastic/Myeloproliferative Neoplasm. Study availability and eligibility vary by location and protocol.
29 public trials
11 recruiting studies
Myelodysplastic/Myeloproliferative Neoplasm trial results
NCT02666950
- Conditions
- Bone Marrow Diseases, Chromosome 5q Deletion Syndrome, Chronic Disease, +18 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
NCT00075478
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, +48 more
- Locations
-
- OHSU Cancer Institute-Southern Region Medford, Oregon, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
Active, Not Recruiting
Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm
NCT05600894
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +20 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UCI Health Laguna Hills Laguna Hills, California, United States
Active, Not Recruiting
Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes
NCT05038592
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
NCT03289910
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid Leukemia, +32 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
Active, Not Recruiting
Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
NCT06034470
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +19 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
NCT02861417
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant
NCT03560752
- Conditions
- Accelerated Phase CML, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +41 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States